Published Tuesday in the journal Cell Metabolism, the study is the latest research to come out of the laboratory of Daniel Drucker, the Canadian scientist renowned for his pioneering research into glucagon-like peptide-1 receptor agonists, or GLP-1s
[Look for] cookbooks that emphasize using food to nourish and teach meal planning, a skill that requires practice and problem-solving, which is critical for long-term health, whether an individual remains on medication or transitions off it, Zimmermann says
Trial participants had a variety of cancers, including biliary tract, bladder, cervical, pancreatic and certain rare tumors
Novo Nordisk's combined expertise in GLP-1 and amylin chemistry enabled this approach
GLP-1 receptor agonists as a class have demonstrated cardiovascular protection in clinical trials, which is particularly valuable in type 2 diabetes
The FDA lists BPC-157 among bulk drug substances used in compounding that present significant safety risks, which limits routine compounding and prescription access in the United States
